跳至主要内容
临床试验/IRCT20240514061800N1
IRCT20240514061800N1尚未招募Unknown

Investigating the effect of the start time of dopamine agonist in antagonist cycles in reducing the rate of ovarian hyperstimulation syndrome

Tehran University of Medical Sciences0 个研究点目标入组 124 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
124

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
Female

入选标准

  • Patients in the age range of 15 to 40, having at least one year of infertility history, patients with polycystic ovary syndrome using the Rotterdam criteria approved by the Rotterdam Joint Group in 2004. These criteria include having 17 or more follicles with a diameter of 10 mm or more on the trigger day, a peak estradiol level above 3,500 pg/ml, use of a GnRH antagonist protocol, use of a GnRH agonist, and cycles in which all embryos were cryopreserved. .

排除标准

  • Having a history of sensitivity to cabergoline and other dopamine agonists, having heart, kidney, and liver disease, low response to ovarian stimulation and thus not being at risk of developing ovarian hyperstimulation syndrome, history of hyperprolactinemia.

研究者

相似试验